KAI-1678: Clinical Trials

3 trials of KAI-1678, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow KAI-1678: new trials by email Literature Review of KAI-1678 trials Research Report on KAI-1678

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia
Placebo, KAI-1678, Lidocaine - Postherpetic Neuralgia
Phase 2CompletedKAI Pharmaceuticals232009-03-012025-09-02
Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Spinal Cord Injury
Placebo, KAI-1678 - Spinal Cord Injury
Phase 2CompletedKAI Pharmaceuticals52009-03-012025-09-02
Safety and Efficacy Study of KAI-1678 to Treat Subjects With Postoperative Pain
Placebo, KAI-1678, Ketorolac Tromethamine - Pain, Postoperative
Phase 2CompletedKAI Pharmaceuticals902008-12-012011-09-02

Conditions studied

Pain, Postoperative (3)  ·  Pain (2)  ·  Neuralgia, Postherpetic (1)  ·  Spinal Cord Injuries (1)

Sponsors

KAI Pharmaceuticals (3)

Countries

Australia (2)  ·  New Zealand (1)

Top investigators

Gregory Bell, MD (3)